Rockefeller Capital Management L.P. Ultragenyx Pharmaceutical Inc. Transaction History

Rockefeller Capital Management L.P.

$36.3 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	SELL	$36.99 - $48.71 $72,093 - $94,935	-1,949 Reduced 23.78%	6,247 $249,000
Q4 2022 Mar 06, 2023	BUY	$33.72 - $46.33 $45,859 - $63,008	1,360 Added 19.89%	8,196 $379,000
Q3 2022 Nov 02, 2022	BUY	$39.96 - $66.14 $134,425 - $222,494	3,364 Added 96.89%	6,836 $282,000
Q2 2022 Aug 12, 2022	BUY	$45.8 - $85.4 $2,656 - $4,953	58 Added 1.7%	3,472 $206,000
Q1 2022 May 13, 2022	SELL	$62.2 - $84.4 $4,229 - $5,739	-68 Reduced 1.95%	3,414 $247,000
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $144,840 - $172,644	1,965 Added 129.53%	3,482 $292,000
Q3 2021 Nov 12, 2021	SELL	$77.92 - $102.4 $4,207 - $5,529	-54 Reduced 3.44%	1,517 $136,000
Q2 2021 Aug 10, 2021	BUY	$92.19 - $115.71 $5,347 - $6,711	58 Added 3.83%	1,571 $149,000
Q1 2021 May 11, 2021	SELL	$106.9 - $167.73 $271,632 - $426,201	-2,541 Reduced 62.68%	1,513 $172,000
Q4 2020 Feb 12, 2021	BUY	$84.4 - $177.39 $159,094 - $334,380	1,885 Added 86.91%	4,054 $560,000
Q3 2020 Nov 13, 2020	BUY	$72.98 - $90.0 $4,013 - $4,950	55 Added 2.6%	2,169 $177,000
Q1 2020 May 12, 2020	SELL	$33.8 - $62.9 $15,649 - $29,122	-463 Reduced 17.97%	2,114 $94,000
Q4 2019 Feb 07, 2020	SELL	$36.08 - $45.83 $5,772 - $7,332	-160 Reduced 5.85%	2,577 $110,000
Q3 2019 Nov 12, 2019	SELL	$42.5 - $63.11 $2,805 - $4,165	-66 Reduced 2.35%	2,737 $117,000
Q2 2019 Aug 09, 2019	BUY	$54.93 - $74.36 $30,870 - $41,790	562 Added 25.08%	2,803 $178,000
Q1 2019 May 10, 2019	BUY	$39.87 - $69.36 $4,983 - $8,670	125 Added 5.91%	2,241 $156,000
Q1 2018 May 09, 2018	BUY	$44.33 - $58.52 $93,802 - $123,828	2,116 New	2,116 $108,000

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.5M

Call Options Held

520K

Put Options Held

406K

Vanguard Group Inc Valley Forge, PA

9.95M
Shares

$427 Million
0.01% of portfolio
Black Rock Inc. New York, NY

5.6M
Shares

$241 Million
0.01% of portfolio
Sands Capital Management, LLC Arlington, VA

5.12M
Shares

$220 Million
0.91% of portfolio
Wellington Management Group LLP Boston, MA

4.17M
Shares

$179 Million
0.04% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.07M
Shares

$132 Million
0.02% of portfolio

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account